| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
April 12, 2017 |
|
|
| |
|
|
| |
|
|
|
Compliance4All, Online
2017-06-22
Overview:
This webinar will address approaches to developing and understanding the
manufacturing process for a drug substance. The information obtained will
enable completion of the drug substance information in Module 3 of a CTD
application.
Why should you Attend:
This presentation is presented in practical language understandable by all
technically educated or trained individuals, regardless of specialty.
Areas Covered in the Session:
Manufacturing process development
Process controls
Selection of starting materials
Control strategy
Process validation evaluation
Submission of information
Life cycle management
Who Will Benefit:
Quality Assurance
Quality Control (Chem and Micro)
Process and Design Engineering
Process Automation
Manufacturing Operations
Validation
Utility Operations
Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com
|
|
|
|
|
|
|
|
Organized by:
|
|
Compliance4All |
|
|
Invited Speakers:
|
|
Speaker Profile:
Peggy J. Berry , MBA, RAC, is the President & CEO at Synergy Consulting
where she provides consulting services to companies in all aspects of drug
development. She also provides group and one-on-one training in drug
development, regulatory affairs and project management topics.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2017-06-21
|
|
|
|
|
|
|
|
Registration:
|
|
Full Details & Registration Link: http://www.compliance4all.com/control/w_product/~product_id=501245LIVE?channel=bio-mirror_Jun_2017_SEO
|
|
|
E-mail:
|
|
support@compliance4All.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|